Today, we’re excited to announce the launch of two provider-friendly new features in Review.
Since before Review was Review (some of you may remember a now-retired solution called Grappa), covered entities have been essential partners in Kalderos’ work to eliminate duplicate discounts and strengthen the sustainability of 340B.
Through covered entities’ insights into the 340B program, we’ve developed solutions to support compliance. More importantly, through their insights into provider needs and workflow, and their participation in pilot studies and early adopter programs, covered entities have helped us create solutions that make their own participation in 340B easier, too.
Now, based on covered entity feedback, we’re introducing two features that make Review more transparent and collaborative than ever.
The Impact Summary Dashboard
Covered entities use Review to respond to good faith inquiries and confirm whether a 340B drug was dispensed in a given claim. Their participation is essential, but they can’t always see the full impact of their collaboration. So we created the Impact Summary Dashboard to give covered entities more visibility into the results of their efforts.
“These new features are directly supporting our covered entity users,” says Jyoti Gill, PharmD, customer relationship manager at Kalderos. “We've heard their feedback about having more insights in their data, and we're launching exactly that!”
This customized dashboard is unique to each organization and collects useful data points about the organization’s use of Review; the number, type and estimated value of duplicate discounts they’ve identified; and how their claims data changes over time.
Covered entities can also leverage this data to make process improvements within their own compliance programs, as well as report on their successes to their 340B oversight committees.
By making this data more accessible, Kalderos is building on our own commitment to transparency, too.
The Product Feedback Forum
Review is designed to streamline the good faith inquiry process, enhance communication and support compliance recordkeeping. And while the product was developed with extensive provider feedback and testing, there’s always room to keep improving.
We want Review users to know that we’re prioritizing their experience and perspective, so we’re introducing the Product Feedback Forum to give covered entities a direct line of communication to the product development team.
Using the Product Feedback Forum, covered entity users can make suggestions for product improvements, request new tools and features, and even upvote ideas from peers.
By making our product development cycle more transparent, we’re hoping to enable even stronger collaboration between us and our covered entity partners.